CME Group Inc. (NASDAQ:CME) Shares Sold by TBH Global Asset Management LLC

TBH Global Asset Management LLC decreased its stake in CME Group Inc. (NASDAQ:CME) by 7.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,489 shares of the financial services provider’s stock after selling 285 shares during the period. TBH Global Asset Management LLC’s holdings in CME Group were worth $810,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of CME. Creative Planning grew its holdings in shares of CME Group by 9.3% during the third quarter. Creative Planning now owns 51,255 shares of the financial services provider’s stock worth $11,309,000 after purchasing an additional 4,354 shares during the last quarter. OLD National Bancorp IN boosted its position in shares of CME Group by 20.0% in the 3rd quarter. OLD National Bancorp IN now owns 1,236 shares of the financial services provider’s stock valued at $273,000 after purchasing an additional 206 shares during the period. Allspring Global Investments Holdings LLC grew its stake in CME Group by 14.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 197,571 shares of the financial services provider’s stock worth $43,594,000 after buying an additional 24,643 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in CME Group by 141.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,151 shares of the financial services provider’s stock worth $2,019,000 after buying an additional 5,359 shares during the last quarter. Finally, Leo Wealth LLC acquired a new position in CME Group during the third quarter worth approximately $260,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Keefe, Bruyette & Woods increased their price objective on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Barclays increased their price target on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Morgan Stanley upped their target price on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a report on Wednesday. JPMorgan Chase & Co. raised their price target on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Finally, Citigroup cut CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $236.13.

Insider Buying and Selling at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Up 1.2 %

CME opened at $250.75 on Thursday. The business has a 50 day simple moving average of $236.62 and a 200-day simple moving average of $226.85. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $253.53. The stock has a market capitalization of $90.36 billion, a P/E ratio of 25.93, a P/E/G ratio of 6.75 and a beta of 0.57. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities analysts anticipate that CME Group Inc. will post 10.39 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.99%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio is presently 51.71%.

CME Group announced that its board has approved a stock repurchase program on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.